anti-Tau

drawing of magnifying glass on a brain
Biotech

J&J halts enrollment in trial of AC Immune Alzheimer's drug

Analysts speculated recruitment challenges may be behind the decision.
James Waldron Feb 19, 2026 9:50am
long shot miss basketball hoop fail shoot

J&J's anti-tau antibody posdinemab flops in phase 2

Nov 24, 2025 9:40am
success failure signposts

UCB's tau drug flunks Alzheimer's trial days after Roche's exit

Nov 1, 2024 6:01am
arrow back backwards u-turn turn around reverse

Roche tosses out $120M tau prospect, returning rights to UCB

Oct 22, 2024 8:30am
Alzheimers brain

Roche’s Genentech returns Alzheimer’s assets to AC Immune

Jan 22, 2024 8:47am
green light go go ahead advance yes streetlight

Janssen moves 1 of 2 AC Immune Alzheimer's vaccines to next step

Nov 30, 2022 10:40am